tbuckley/cabot-search huggingface dataset:
Duroziez's Sign.
Journal: JAMA (1933)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mortality factors in patients with acute stroke
Authors: M. Brown
Journal: JAMA (1973)

Although cerebrovascular disease is the third most common cause of death in the United States, there is little information about the actual mechanism of death in patients with an acute, terminal stroke. We have investigated the records of 200 patients who were admitted to the Evanston Hospital with the diagnosis of stroke, died, and had autopsies. Our data show that patients who died within a week after onset presented important differences in the probable causes of death from those who died later. In the latter group, death appeared much more frequently to be due to nonneurologic diseases such as pneumonia, pulmonary embolism, and urinary tract infections.
Scintiangiography of Hepatic Masses in Childhood
Authors: Gary F. Gates, John H. Miller, Philip Stanley
Journal: JAMA (1978)

Forty-three children with intrahepatic masses had technetium Tc 99m sulfur colloid hepatic scintigrams including scintiangiography. Hypervascularity occurred in nearly one third of the masses, but was limited to children with primary liver tumors including hepatomas, hepatoblastomas, hepatic adenomas, and cavernous hemangiomas. All metastases, abscesses, and hematomas were hypovascular. Routine inclusion of scintiangiography may allow separation of primary hypervascular liver tumors from other hypovascular masses whose static hepatic scintigrams are virtually identical. (<i>JAMA</i>239:2667-2670, 1978)
Personal View
Authors: F. Arnold
Journal: BMJ (1991)

Blood lead concentration was measured in 398 male and 133 female London civil servants not subject to industrial exposure to heavy metals. The relation between blood lead and serum creatinine concentrations and blood pressure were examined. Blood lead concentration ranged from 0.20 to 1.70 mumol/l with a geometric mean concentrations of 0.58 mumol/l in men and 0.46 mumol/l in women (p less than 0.001). In women blood lead concentration increased with age (r = +0.27; p = 0.002). In the two sexes blood lead concentration was positively correlated with the number of cigarettes smoked a day (men r = +0.17 and women r = +0.22; p less than or equal to 0.01), with the reported number of alcoholic beverages consumed a day (men r = +0.34 and women r = 0.23; p less than 0.01), and with serum gamma-glutamyltranspeptidase (men r = +0.23 and women r = +0.14; for men p less than 0.01). Blood lead concentration was not correlated with body weight, body mass index, and employment grade. In men 14% of the variance of blood lead concentration was explained by the significant and independent contributions of smoking and alcohol intake and in women 16% by age, smoking, and alcohol consumption. In men serum creatinine concentration tended to rise by 0.6 mumol/l (95% confidence interval from -0.2 to +1.36 mumol/l) for each 25% increment in blood lead concentration. In men and women the correlations between blood lead concentration and systolic and diastolic blood did not approach statistical significance. In conclusion, in subjects not exposed to heavy metals at work gender, age, smoking, and alcohol intake are determinants of blood lead concentration. At a low level of exposure, lead accumulation may slightly impair renal function, whereas blood pressure does not seem to be importantly influenced. Alternatively, a slight impairment of renal function may give rise to an increase in blood lead concentration.
A Hemato-Respiratory Study of 101 Consecutive Cases of Stammering.
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cannabis Roots
Authors: David S. Hedrick
Journal: JAMA (1971)

<h3>To the Editor.—</h3> Probably it is incorrect to identfy as<i>Cannabis</i>the "Indian hemp" root referred to by Rodger (<b>217</b>:1705, 1971) as having digitalis-like properties. <i>Cannabis</i>, an old-world plant, probably was unknown to North American Indian herbalists. However, several plants used by American Indians as fiber sources are commonly known as Indian Hemp, particularly<i>Apocynum cannabinum</i>. These plants are unrelated to<i>Cannabis</i>, the only similarity being useful fibers.
Aripiprazole in the Treatment of Patients With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Study
Authors: Marius Nickel
Journal: American Journal of Psychiatry (2006)

Objective: Aripiprazole is a relatively new atypical antipsychotic agent that has been successfully employed in therapy for schizophrenia and schizoaffective disorders. A few neuroleptics have been used in therapy for patients with borderline personality disorder, which is associated with severe psychopathological symptoms. Aripiprazole, however, has not yet been tested for this disorder, and the goal of this study was to determine whether aripiprazole is effective in the treatment of several domains of symptoms of borderline personality disorder. Method: Subjects meeting criteria for the Structured Clinical Interview for DSM-III-R Personality Disorders for borderline personality disorder (43 women and 9 men) were randomly assigned in a 1:1 ratio to 15 mg/day of aripiprazole (N=26) or placebo (N=26) for 8 weeks. Primary outcome measures were changes in scores on the symptom checklist (SCL-90-R), the Hamilton Depression Rating Scale (HAM-D), the Hamilton Anxiety Rating Scale (HAM-A), and the State-Trait Anger Expression Inventory and were assessed weekly. Side effects and self-injury were assessed with a nonvalidated questionnaire. Results: According to the intent-to-treat principle, significant changes in scores on most scales of the SCL-90-R, the HAM-D, the HAM-A, and all scales of the State-Trait Anger Expression Inventory were observed in the subjects treated with aripiprazole after 8 weeks. Self-injury occurred in the groups. The reported side effects were headache, insomnia, nausea, numbness, constipation, and anxiety. Conclusions: Aripiprazole appears to be a safe and effective agent in the treatment of patients with borderline personality disorder.
Fifth Multidiscipline Research Forum of the American Medical Association
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
British Thoracic Society guideline for respiratory management of children with neuromuscular weakness
Authors: Jeremy Hull, Roona Aniapravan, Elaine Chan, Michelle Chatwin, Julian Forton, Jayne Gallagher, Neil Gibson, Jill Gordon, Imelda Hughes, Renee McCulloch, Robert Ross Russell, Anita Simonds
Journal: Thorax (2012)

< Acknowledgement of stress factors and mental health issues, requirement for wider support through organizations, and practical and focused individual care are needed for patients and their parents or carers.[D] <Routine pain evaluation should be part of standard clinical assessment in all children and young people with neuromuscular disorders.[D] < Attention to the wider physical impact of chronic illness through vigilant symptom management is required.[D] < Dyspnoea is a subjective feeling, which can respond to non-drug measures and treatment directed at the cause.[O] <Low-dose opioids may be used to manage distressing breathlessness even when active treatment is pursued.With slow titration of opioids, respiratory depression is extremely unlikely.[O] <In the terminal phase of respiratory failure, symptoms must be reassessed frequently and can be effectively managed by a multimodal approach, including careful titration of opioids and psychotropic agents.[O] < Advance care planning should be an integral part of the active management of children and young people with neuromuscular disorders.Advance care plans can be used as a vehicle for information exchange and considered decision-making.[D] < Patients and families need to have ownership of the advance care plan and be educated as to its uses.[D] < Advance care plans should be reviewed by the multidisciplinary team on a regular basis.[O] <Families need access to skilled experts for multidimensional coordinated palliative care support, providing regular review of their needs at various stages in their condition.[D] < Generic palliative care skills should be cascaded to other professionals providing neuromuscular services.[O] Special considerations<Carers and parents of children with severe NMW, including all those using NIV and all those with tracheostomy, should have basic life support training.[O] <Written plans for the management of acute exacerbations, which include details of effective airway clearance methods and ventilator settings when appropriate, and contact details of relevant healthcare professionals are recommended.
PTH-058 Long-term prognosis of patients presenting with gastrointestinal symptoms and abnormal calprotectin diagnosed with non-organic disease
Authors: P Pavlidis, S Pal, G Chung-Faye, B Hayee
Journal: Gut (2015)

<h3>Introduction</h3> Faecal calprotectin (fcal) is a non-invasive marker of intestinal inflammation that can assist physicians in investigating chronic gastrointestinal (GI) symptoms. Different cut-off values have been proposed, depending on the pre-test probability for organic disease, in order to improve diagnostic accuracy and to make the test more cost-effective. To support the use of a higher cut-off in clinical practice, we present data from a cohort of patients having been fully investigated for fcal levels above the lab reference cut-off. <h3>Method</h3> Retrospective observational study. <h3>Results</h3> We identified the patients who were referred to the Gastroenterology department at King’s College Hospital, London, UK between January 2002 and 2004 with chronic gastrointestinal symptoms and had a fcal test. During this period 367 patients were tested. Two hundred (200/367, 55%) were given a diagnosis of non-organic disease and were discharged to their primary care physician. Sixty one (61/200, 31%) with a median age of 48 years (range 21, 85) and 2:1 female: male ratio tested positive for fcal (&gt;60 μg/g, ELISA kit, Bühlmann). Thirty five (35/61, 57%) had presented initially with altered bowel habit, 15 (25%) with abdominal pain, 7 (12%) with bloating and 4 (6%) with diarrhoea. The median fcal was 113 μg/g (range 60, 850, &gt;150 μg/g in 18 [30%] patients). All had a normal ileocolonoscopy. The median follow up time from initial presentation to the initiation of this study was 10 years (range 9, 11). In this period 3 patients (3/61, 5%) were diagnosed with an organic condition. Two were diagnosed with Crohn’s disease (1 with terminal ileal [TI] and 1 with isolated perianal disease) after 7 years of their initial presentation and 1 with collagenous colitis after 5 years. The repeat fcal for the patient with TI disease increased from 80 μg/g to 1130 μg/g prior to diagnosis. The other two had normal fcal when retested. Four patients were found, in retrospect, to take NSAIDs regularly, three had a diagnosis of cystic fibrosis, two with liver cirrhosis and one had a diagnosis of HIV at the time of referral. None of the patients with a negative calprotectin developed organic disease during their follow-up. <h3>Conclusion</h3> In patients presenting with chronic GI symptoms, fcal in the range 60–150 μg/g is associated with a very low incidence of organic or significant pathology. Subsequent routine investigation of these patients after normal colonoscopy (other than perhaps repeating fcal to demonstrate a trend over time) is not recommended. <h3>Disclosure of interest</h3> None Declared.
Inappropriate Title.
Journal: JAMA (1996)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
International Clinics: a Quarterly of Clinical Lectures on Medicine, Neurology, Pediatrics, Surgery, Genito-Urinary Surgery, Gynecology, Ophthalmology, Laryngology, Otology, and Dermatology.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
What patients want: the full facts, please
Authors: P. Gunby
Journal: JAMA (1982)

Patients are more likely to refuse treatment if they receive too little information or there are "other lapses in communication" between them and medical personnel, says the President's Commission on Ethics in Medicine and Research. The 11-member commission, which includes seven physicians, drew this conclusion from national surveys of physicians and the public conducted for it by Louis Harris and Associates and from studies of physician-patient decision-making conducted at the University of Pittsburgh. Members of the commission say the conclusion is "contrary to the fears of many that too much information frightens patients." The commission, which was created by Congress, has been meeting since January 1980 and will be dissolved at the end of this year. In reporting the results of its latest studies to Congress and the President, it concluded that it isn't "fruitful to rely primarily on legal reforms to overcome the failure of a real process of
皮肤病在五个欧洲国家基于人口的成人样本中的流行性
Authors: A. Svensson, R.F. Ofenloch, M. Bruze, L. Naldi, S. Cazzaniga, P. Elsner, M. Goncalo, M.-L.A. Schuttelaar, T.L. Diepgen
Journal: British Journal of Dermatology (2018)

该研究所基于的调查由五个不同欧洲国家(德国、意大利、荷兰、葡萄牙和瑞典)对皮肤病流行病学感兴趣的研究人员开展。流行病学研究的是疾病的“对象、时间和区域”,分析特定疾病的患者和病因。该研究旨在展现皮肤病在这些不同地区的模式。共有12377名18至74岁的参与者填写了调查问卷,调查目的在于记录其一生、去年和上一个月的皮肤状况。为确保有效性,还收集了诊断医师和治疗方法的详细信息。患者表示其一生中最常见的皮肤病为疣(41.3%)、痤疮(19.2%)和接触性皮炎(15.0%),其次则是其他形式的湿疹和过敏性皮肤炎、其他皮肤病以及荨麻疹。一般来说,女性比男性更易得皮肤病,但是男性得皮肤癌的比例更高。总体而言,皮肤病在北欧国家(德国、荷兰和瑞典)比南欧(意大利和西班牙)更为常见。尽管在大部分国家或地区,通常由皮肤科医生进行诊断和治疗,但是在荷兰,还经常涉及到其他医生,例如全科医师。
Error in a Figure
Authors: Carrol Gamble, Steff Lewis, Stephen Senn
Journal: JAMA (2018)

Diana M. Sobieraj, PharmD; William L. Baker, PharmD; Elaine Nguyen, PharmD, MPH; Erin R. Weeda, PharmD; Craig I. Coleman, PharmD; C. Michael White, PharmD; Stephen C. Lazarus, MD; Kathryn V. Blake, PharmD; Jason E. Lang, MD, MPH
Blood banking automation
Authors: C. F. Wolf
Journal: JAMA (1978)

THE INCOMPATIBLE blood transfusion remains a great danger in hemotherapy. It perhaps is most hazardous to the patient when it involves his receiving incompatible red blood cells. Pain, shock, chills, fever, and renal failure with acute tubular necrosis, abnormal bleeding due to disseminated intravascular coagulation, and death can result. Modern blood bank laboratory techniques readily recognize most incompatibilities in the test tube, and new automated testing equipment is further reducing the chances for technical errors. As a result, incompatible blood transfusions mostly result from human error,<sup>1</sup>which can occur from before the drawing of blood up to the moment of transfusion. Human error refers to clerical errors made identifying patient specimens; in transcribing information from the donor record to the blood-bag label, from the label to various recording sheets and logbooks, from one label to another label; and most important, in matching donor blood information with intended recipient requirements
Blood coagulation following vasectomy
Authors: C. T. Kisker
Journal: JAMA (1979)

Concern that men may have an increased risk of the development of thrombophlebitis following vasectomy prompted the study of 58 vasectomized men and 37 age-matched controls. Eight patients undergoing total hip replacement also were studied, since they are known to have an increased risk of thrombotic complications. There were no changes in coagulation suggestive of a thrombotic tendency in the vasectomized population, though an increase in fibrinogen concentration was present preoperatively, and transient increases in factor V concentration, prothrombin time, and fibrinogen concentration were seen postoperatively in some cases. None of the vasectomized patients had clinical evidence suggestive of thrombosis. (<i>JAMA</i>241:1595-1598, 1979)
HIV infection and risk behaviors among heterosexuals in alcohol treatment programs
Authors: A. L. Avins
Journal: JAMA (1994)

<h3>Objective.</h3> —To measure the prevalence of human immunodeficiency virus (HIV) infection and high-risk behaviors among heterosexuals in alcohol treatment. <h3>Design.</h3> —Cross-sectional survey. <h3>Setting.</h3> —Five public alcohol treatment centers. <h3>Subjects.</h3> —Consecutive sample of 888 heterosexual clients entering treatment between October 1990 and December 1991. Respondents were 51% black, 10% Hispanic, 33% white, and 76% male. The overall response rate was 68%. <h3>Measurements.</h3> —Structured interview and serotesting for HIV antibodies. <h3>Results.</h3> —The overall seroprevalence of HIV infection was 5% (95% confidence interval, 3% to 6%). There were no significant differences in rates of infection by age, gender, or race. The prevalence of infection in heterosexual respondents without a history of injection drug use was 3% in men and 4% in women, several times higher than published estimates from a similar community-based heterosexual sample. Unsafe sexual practices were common: 54% of respondents reported multiple sexual partners in the previous year, 97% of nonmonogamous respondents did not use condoms during all sexual encounters, and few respondents consistently asked new sexual partners about previous high-risk behaviors. <h3>Conclusions.</h3> —There is a substantial prevalence of HIV infection among heterosexual clients in San Francisco (Calif) alcohol treatment programs, much of which is not associated with injection drug use. Because of this and the high prevalence of unsafe sexual behaviors, there is a relatively high likelihood of heterosexual spread of HIV among the large population of clients seeking treatment for alcohol dependency. Interventions to prevent HIV spread should become a standard part of alcohol treatment programs. (<i>JAMA</i>. 1994;271:515-518)